← SynDRA
NERIGLIATIN
SynDRA canonical compound SYN0034111 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | GCK |
|---|
| Mechanism of action | glucokinase activator |
|---|
All known targets
Mechanisms of action (all sources)
- GCK ACTIVATOR
- Hexokinase type IV activator
- glucokinase activator
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HDAC6
- KCNH2
- SLCO1B1
- SLCO1B3
Cross-references
Synonyms
- Nerigliatine
- Nerigliatina
- PF-04937319
- Pf-04937319
- 7E99B9ZM19
- RefChem:172236
- MASKQITXHVYVFL-UHFFFAOYSA-N
- S41
- nerigliatin [INN]
- MFCD26960571
- Nerigliatin [WHO-DD]
- UNII-7E99B9ZM19
- orb1307905
- SCHEMBL1720691
- SCHEMBL29411291
- C22H20N6O4
- VZB60392
- BDBM50394684
- AKOS032962871
- EBC-498100
- SB17402
- DA-56717
- MS-27712
- HY-108328
- CS-0028321
- G14309
- T16479
- PF-04937319, >=98% (HPLC)
- BRD-K27755542-001-01-6
- N,N-dimethyl-5-({2-methyl-6-[(5-methylpyrazin-2-yl)carbamoyl]-1-benzofuran-4-yl}oxy)pyrimidine-2-carboxamide
Look up NERIGLIATIN in the interactive SynDRA portal →